For Perimenopause

GLP-1 weight loss for the perimenopause years.

Physician-reviewed care for the metabolic shift in your 40s

Perimenopause is when the metabolism starts shifting and the strategies that worked at 35 stop delivering. Estrogen fluctuates, insulin sensitivity drops, lean muscle declines, and abdominal fat creeps up. GLP-1 medications address several of these changes at once. A licensed Puri-affiliated physician can evaluate whether compounded semaglutide or tirzepatide may fit your care plan.

Perimenopause and GLP-1: the practical overview.

Quick summary

Perimenopause and GLP-1: the practical overview.

Perimenopause typically lasts 4-8 years and brings real metabolic changes: hormonal fluctuation, declining insulin sensitivity, lean muscle loss, sleep disruption, and shifting fat distribution toward the abdomen. The strategies that worked in your 30s often stop working. GLP-1 medications address several of these mechanisms simultaneously and have shown weight loss in midlife women in clinical trials of brand-name products.

Compounded semaglutide starts at $179/mo and compounded tirzepatide starts at $249/mo through Puri. A licensed provider makes the prescribing decision based on your clinical picture, including any hormone therapy you may be on. A prescription is not guaranteed.

4-8 yrs
Transition window
Average length
1%/yr
Muscle loss
After 40 without strength work
30%+
Visceral fat
Common shift toward abdomen

The Complete Guide

Perimenopause weight loss with GLP-1: what really works in the 40s

A practical, research-grounded guide for women in their 40s navigating the metabolic shift before menopause.

Reviewed by Puri's care team12 minute read

Perimenopause is not menopause

Perimenopause is the transitional period before menopause, when the ovaries gradually slow down hormone production but periods have not yet stopped. It typically begins in a woman's mid-40s, though it can start as early as the late 30s. The transition itself can last 4 to 8 years, sometimes longer. Menopause — defined as 12 consecutive months without a period — is the end of that transition, not the start of it.

What makes perimenopause clinically different from menopause is the unpredictability. Estrogen does not just gradually decline; it fluctuates wildly. One month is normal, the next month is a hormonal rollercoaster. That instability is what produces the classic perimenopause symptoms: irregular periods, sleep disruption, mood changes, hot flashes, and — the part most women want to talk about — weight gain that does not respond to the strategies that worked five years earlier.

If you are in your 40s and the diet that used to work has stopped working, the explanation is biological, not behavioral. Your hormones, your insulin sensitivity, your sleep quality, and your muscle mass are all changing simultaneously. The strategies that fit your body at 35 do not necessarily fit your body at 45.

Why weight changes during perimenopause

Several things shift at the same time, and the combined effect is bigger than any one of them alone:

  • Estrogen decline. Estrogen helps regulate where the body stores fat (more in the hips and thighs in younger women, more in the abdomen as estrogen falls). It also influences insulin sensitivity. As estrogen drops, visceral fat increases and insulin sensitivity worsens — a double hit on the metabolism.
  • Loss of lean muscle. Muscle is metabolically expensive tissue. Most adults lose about 1% of muscle mass per year after age 40 if they don't strength train. Less muscle means a lower resting metabolic rate.
  • Sleep disruption. Hot flashes, night sweats, and hormonal mood shifts wreck sleep for many perimenopausal women. Poor sleep increases cortisol, increases hunger hormones, and worsens insulin resistance. Compounding losses.
  • Cortisol shifts. Many women in perimenopause are also navigating peak life stress — careers, parenting, aging parents. Chronic cortisol elevation directly drives abdominal fat storage.
  • Activity decline. Joint pain and time scarcity in midlife cut total daily activity for many women, often without them noticing.

Related: menopause guide for what changes after the transition is complete.

Where GLP-1 medications fit in the perimenopause picture

GLP-1 receptor agonists like semaglutide and tirzepatide directly address several of the metabolic changes happening during perimenopause: they improve insulin sensitivity, reduce appetite (which counteracts the cortisol-driven hunger), and drive sustained weight loss in clinical trials of brand-name FDA-approved versions. The STEP and SURMOUNT trial programs both included subgroups of women in midlife and reported similar weight loss to younger participants.

What GLP-1 will not do: replace estrogen, eliminate hot flashes, fix sleep disruption, or build muscle. Those are separate tools (hormone therapy, sleep hygiene, strength training). GLP-1 is one lever among several. The most successful patients in midlife pull on more than one lever at a time.

Compounded versions of these medications have not been studied in the same way as brand-name products. The available evidence on perimenopause-specific effects is limited. A licensed physician evaluates the prescribing decision based on your individual situation.

Stacking tools that work together

  • Strength training, twice a week. The single most effective intervention for preserving muscle mass during the perimenopause transition. You don't need to live in the gym — two sessions of compound lifts (squats, deadlifts, presses, rows) delivers most of the benefit.
  • Protein. Aim for 1g per pound of goal body weight to preserve lean mass during weight loss. GLP-1 reduces appetite so getting enough protein takes intention.
  • Sleep, treated as medicine. If hot flashes or hormonal shifts are wrecking your sleep, talk to a physician about hormone therapy. Sleep is the foundation under everything else.
  • Hormone therapy if appropriate. Modern menopausal hormone therapy is safer than many women were led to believe by the early 2000s headlines. The North American Menopause Society's position statement is the current authoritative guidance. Many women on hormone therapy can also use GLP-1 medications under physician supervision.
  • Reduce alcohol. Alcohol disrupts sleep, raises cortisol, and adds calories. Most perimenopausal women feel a noticeable improvement when they cut back significantly.

How to get started

If you are in perimenopause and frustrated with weight that won't move, the first conversation is with a physician who treats midlife metabolic change, not just symptoms. Complete your assessment. Bring your medical history, your current medications (including hormone therapy if applicable), and your goals. A licensed Puri-affiliated physician will review and decide whether GLP-1 is the right next step. A prescription is not guaranteed.

Cited sources

Where the evidence comes from.

The research referenced throughout this guide draws from peer-reviewed clinical studies and guidelines published by medical professional societies. The studies describe findings for specific brand-name GLP-1 products. They do not represent promises of individual outcomes, and they do not apply directly to compounded medications.

Where the evidence comes from.

The North American Menopause Society publishes the authoritative position statements on perimenopause and menopause management, including weight, body composition, and hormone therapy guidance.

The Menopause Society

The Endocrine Society publishes peer-reviewed clinical practice guidelines on hormone therapy and metabolic care in midlife women.

Endocrine Society Clinical Guidelines

The STEP and SURMOUNT clinical trial programs studied semaglutide and tirzepatide in adults with obesity, including subgroups of midlife women.

PubMed: GLP-1 weight loss trials

The National Institute on Aging publishes educational resources on body composition changes and healthy aging in midlife women.

NIH National Institute on Aging

The US Food and Drug Administration publishes prescribing information for FDA-approved GLP-1 products including indicated uses, dosing, and safety data.

FDA Drug Information

These links are provided for educational reference. Puri is not affiliated with these organizations. GLP-1 medications referenced may not be FDA-approved for the specific condition discussed. Compounded versions are not FDA-approved for any indication. Always talk to your healthcare provider before starting any new medication.

Programs

GLP-1 options available through Puri

Every plan includes a physician review, personalized dosing, provider messaging, and free shipping. A prescription is not guaranteed and requires licensed provider approval.

Most Popular

Compounded Semaglutide

$179/mo
  • Weekly self-injection
  • Compounded (not FDA-approved)
  • Personalized dosing
  • Provider oversight included
  • Free expedited shipping
Get Started

Compounded Tirzepatide

$249/mo
  • Weekly self-injection
  • Dual GLP-1 and GIP activity
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free expedited shipping
Get Started

Oral GLP-1 Tablets

$249/mo
  • No injections needed
  • Daily oral tablet
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free shipping
Get Started

Process

How it works

Three simple steps to start your journey

Get Approved
1

Get Approved

Complete a quick online evaluation to determine if treatment is right for you. No payment required upfront.

Get Prescribed
2

Get Prescribed

Once approved, a licensed provider will create a personalized treatment plan tailored to your needs and goals.

Receive Your Rx
3

Receive Your Rx

Your medication will be shipped directly to your door with free expedited delivery in discreet packaging.

FAQ

Common questions about perimenopause and GLP-1

Educational answers, not medical advice.

Satisfaction Guarantee

Care that puts you first.

Personalized support from licensed providers, with a satisfaction guarantee on your first month (terms apply). Individual results vary. Outcomes are not guaranteed.